Latest Breaking News On - Atrin pharmaceuticals inc - Page 1 : comparemela.com

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a

First-in-class macrocyclic ATR inhibitor, ATRN-119, on track to complete dose escalation and potentially generate human efficacy data in H2 2024

United statesUniversity of pennsylvaniaNadeem mirzaOren giladTimothy yapEric brownFiona simpkinsMike moyerAmerican association of cancer researchSecurities exchangeAtrin pharmaceuticals incExchange commissionAbramson family cancer research instituteUniversity of texas md anderson cancer centerDivision of gynecology oncologyAprea therapeutics inc

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of pennsylvaniaTimothy yapEric brownOren giladMike moyerFiona simpkinsNadeem mirzaDivision of gynecology oncologyAmerican association of cancer researchAtrin pharmaceuticals incSecurities exchangeCenter evaluationExchange commissionAprea therapeutics incAbramson family cancer research institute

Aprea Therapeutics Announces Poster Presentation at the

BOSTON, Sept. 22, 2022 (GLOBE NEWSWIRE) Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel synthetic.

United statesGregorya korbelOren giladScottm coianteAprea therapeutics incAtrin pharmaceuticals incExchange commissionAmerican association for cancer researchVirtual ovarian cancer research seminar seriesRivkin centerSecurities exchangeAmerican associationCancer researchChief executive officerAprea therapeuticsSecurities act

Aprea Therapeutics Announces Poster Presentation at the 2022 Rivkin Center and American Association for Cancer (AACR) Virtual Ovarian Cancer Research Seminar Series

Aprea Therapeutics Announces Poster Presentation at the 2022 Rivkin Center and American Association for Cancer (AACR) Virtual Ovarian Cancer Research Seminar Series
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesScottm coiantesrOren giladGregorya korbelsrAprea therapeutics incAtrin pharmaceuticals incExchange commissionRivkin centerAmerican association for cancer researchVirtual ovarian cancer research seminar seriesSecurities exchangeAmerican associationCancer researchChief executive officerAprea therapeuticsSecurities act

Aprea Therapeutics Announces Poster Presentation at the 2022 Rivkin Center and American Association for Cancer (AACR) Virtual Ovarian Cancer Research Seminar Series

United statesGregorya korbelOren giladScottm coianteAprea therapeutics incAtrin pharmaceuticals incExchange commissionRivkin centerAmerican association for cancer researchVirtual ovarian cancer research seminar seriesSecurities exchangeAmerican associationCancer researchChief executive officerAprea therapeuticsSecurities act